2025 Q4 -tulosraportti
11 päivää sitten
‧30 min
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 14.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 3.3. | ||
2025 Q3 -tulosraportti 12.11.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 20.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·6 t sittenEveryone is starting to sell out here, does anyone know something we don't know. https://newsweb.oslobors.no/message/668351
·3 t sittenHe used 615,196 subscription rights on March 9 and later the remaining 90,000 subscription rights and thus has approximately half a million more shares than before.
·7 t sittenHere is a short and easily understandable summary from Gemini of what the news means for Lifecare: 1. What has happened? The EU's expert panel (Innovation Radar) has named Lifecare a "Key Innovator". The EU has scrutinized the company and confirms that their unique method for measuring blood sugar (without needles and enzymes) is technologically mature and has enormous market potential. 2. Why is this so big (Strategic value)? Removes crisis mood: Just days before, Lifecare received a temporary rejection from Legemiddelverket (NOMA) to start human testing. This created fear that the technology did not work. The EU news acts as an enormous seal of quality proving that the technology is world-class. It confirms that the problems with NOMA are only about bureaucracy and paperwork (ISO certifications), not that the sensor itself is bad. Door opener: The EU recognition gives Lifecare a "fast-track" to large European investors and tens of millions in potential new funding. 3. What is it worth in kroner and øre? Short-term cash value (Saved the company): The news came at a critical time. The company was in the process of raising money via subscription rights (warrants) which expired on March 13. For investors to inject the money, the share price had to stay up. The EU news saved the price, investors bought the shares, and Lifecare secured over 35 million kroner in vital, fresh capital directly into the account. Long-term company value: American Senseonics, which is Lifecare's closest competitor, is worth around 3 billion Norwegian kroner. Lifecare has been priced very low due to high risk. By the EU now removing the technological uncertainty, it is estimated that the news, in isolation, raises the underlying, fundamental value of the company by approximately 150 to 225 million kroner. In short: The EU stamp saved the company from an acute cash shortage and proved to the market that their science actually works.
·10 t sitten · MuokattuAnd there Andreas Pfützner resigned as Chief Scientific Officer (CSO), so I guess everything is going smoothly now? After today's collapse and the indications from Finansavisen about how Life frantically issued a stock exchange announcement yesterday, it's no surprise that today's stock exchange announcement about Pfützner comes after market close. How far down on Monday? Below 0.3342? 😵💫
·9 t sittenStraw man argument. This is completely undramatic, and it doesn't say anything about him "resigning immediately" or similar. Talented people move on when the job is done because they want new challenges. Lifecare is in a new phase, but Prof. Pfützner will participate as support when needed.- ·11 t sittenTeigland eiendom As bought subscription shares for 0.3342 and sold the shares to small shareholders for 0.4824. 😁. And that's what they will continue with. Poor you.·9 t sittenIt's surely not uncommon for someone trading shares to want to make money? Teigland is a supporter of Lifecare, and helps ensure that the company can reach its goal.
- ·12 t sitten83% of the subscription rights were exercised. That is a big victory for Lifecare. Those who have exercised the subscription rights will receive the shares on March 26th or around then. Lifecare now has capital to continue.·1 t sittenI think they are burning approx. 5 million per month currently (I'm not entirely sure). The money should last for over half a year.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
11 päivää sitten
‧30 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·6 t sittenEveryone is starting to sell out here, does anyone know something we don't know. https://newsweb.oslobors.no/message/668351·3 t sittenHe used 615,196 subscription rights on March 9 and later the remaining 90,000 subscription rights and thus has approximately half a million more shares than before.
- ·7 t sittenHere is a short and easily understandable summary from Gemini of what the news means for Lifecare: 1. What has happened? The EU's expert panel (Innovation Radar) has named Lifecare a "Key Innovator". The EU has scrutinized the company and confirms that their unique method for measuring blood sugar (without needles and enzymes) is technologically mature and has enormous market potential. 2. Why is this so big (Strategic value)? Removes crisis mood: Just days before, Lifecare received a temporary rejection from Legemiddelverket (NOMA) to start human testing. This created fear that the technology did not work. The EU news acts as an enormous seal of quality proving that the technology is world-class. It confirms that the problems with NOMA are only about bureaucracy and paperwork (ISO certifications), not that the sensor itself is bad. Door opener: The EU recognition gives Lifecare a "fast-track" to large European investors and tens of millions in potential new funding. 3. What is it worth in kroner and øre? Short-term cash value (Saved the company): The news came at a critical time. The company was in the process of raising money via subscription rights (warrants) which expired on March 13. For investors to inject the money, the share price had to stay up. The EU news saved the price, investors bought the shares, and Lifecare secured over 35 million kroner in vital, fresh capital directly into the account. Long-term company value: American Senseonics, which is Lifecare's closest competitor, is worth around 3 billion Norwegian kroner. Lifecare has been priced very low due to high risk. By the EU now removing the technological uncertainty, it is estimated that the news, in isolation, raises the underlying, fundamental value of the company by approximately 150 to 225 million kroner. In short: The EU stamp saved the company from an acute cash shortage and proved to the market that their science actually works.
- ·10 t sitten · MuokattuAnd there Andreas Pfützner resigned as Chief Scientific Officer (CSO), so I guess everything is going smoothly now? After today's collapse and the indications from Finansavisen about how Life frantically issued a stock exchange announcement yesterday, it's no surprise that today's stock exchange announcement about Pfützner comes after market close. How far down on Monday? Below 0.3342? 😵💫·9 t sittenStraw man argument. This is completely undramatic, and it doesn't say anything about him "resigning immediately" or similar. Talented people move on when the job is done because they want new challenges. Lifecare is in a new phase, but Prof. Pfützner will participate as support when needed.
- ·11 t sittenTeigland eiendom As bought subscription shares for 0.3342 and sold the shares to small shareholders for 0.4824. 😁. And that's what they will continue with. Poor you.·9 t sittenIt's surely not uncommon for someone trading shares to want to make money? Teigland is a supporter of Lifecare, and helps ensure that the company can reach its goal.
- ·12 t sitten83% of the subscription rights were exercised. That is a big victory for Lifecare. Those who have exercised the subscription rights will receive the shares on March 26th or around then. Lifecare now has capital to continue.·1 t sittenI think they are burning approx. 5 million per month currently (I'm not entirely sure). The money should last for over half a year.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 14.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 3.3. | ||
2025 Q3 -tulosraportti 12.11.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 20.2.2025 |
2025 Q4 -tulosraportti
11 päivää sitten
‧30 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 14.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 3.3. | ||
2025 Q3 -tulosraportti 12.11.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 20.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·6 t sittenEveryone is starting to sell out here, does anyone know something we don't know. https://newsweb.oslobors.no/message/668351·3 t sittenHe used 615,196 subscription rights on March 9 and later the remaining 90,000 subscription rights and thus has approximately half a million more shares than before.
- ·7 t sittenHere is a short and easily understandable summary from Gemini of what the news means for Lifecare: 1. What has happened? The EU's expert panel (Innovation Radar) has named Lifecare a "Key Innovator". The EU has scrutinized the company and confirms that their unique method for measuring blood sugar (without needles and enzymes) is technologically mature and has enormous market potential. 2. Why is this so big (Strategic value)? Removes crisis mood: Just days before, Lifecare received a temporary rejection from Legemiddelverket (NOMA) to start human testing. This created fear that the technology did not work. The EU news acts as an enormous seal of quality proving that the technology is world-class. It confirms that the problems with NOMA are only about bureaucracy and paperwork (ISO certifications), not that the sensor itself is bad. Door opener: The EU recognition gives Lifecare a "fast-track" to large European investors and tens of millions in potential new funding. 3. What is it worth in kroner and øre? Short-term cash value (Saved the company): The news came at a critical time. The company was in the process of raising money via subscription rights (warrants) which expired on March 13. For investors to inject the money, the share price had to stay up. The EU news saved the price, investors bought the shares, and Lifecare secured over 35 million kroner in vital, fresh capital directly into the account. Long-term company value: American Senseonics, which is Lifecare's closest competitor, is worth around 3 billion Norwegian kroner. Lifecare has been priced very low due to high risk. By the EU now removing the technological uncertainty, it is estimated that the news, in isolation, raises the underlying, fundamental value of the company by approximately 150 to 225 million kroner. In short: The EU stamp saved the company from an acute cash shortage and proved to the market that their science actually works.
- ·10 t sitten · MuokattuAnd there Andreas Pfützner resigned as Chief Scientific Officer (CSO), so I guess everything is going smoothly now? After today's collapse and the indications from Finansavisen about how Life frantically issued a stock exchange announcement yesterday, it's no surprise that today's stock exchange announcement about Pfützner comes after market close. How far down on Monday? Below 0.3342? 😵💫·9 t sittenStraw man argument. This is completely undramatic, and it doesn't say anything about him "resigning immediately" or similar. Talented people move on when the job is done because they want new challenges. Lifecare is in a new phase, but Prof. Pfützner will participate as support when needed.
- ·11 t sittenTeigland eiendom As bought subscription shares for 0.3342 and sold the shares to small shareholders for 0.4824. 😁. And that's what they will continue with. Poor you.·9 t sittenIt's surely not uncommon for someone trading shares to want to make money? Teigland is a supporter of Lifecare, and helps ensure that the company can reach its goal.
- ·12 t sitten83% of the subscription rights were exercised. That is a big victory for Lifecare. Those who have exercised the subscription rights will receive the shares on March 26th or around then. Lifecare now has capital to continue.·1 t sittenI think they are burning approx. 5 million per month currently (I'm not entirely sure). The money should last for over half a year.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - | ||
| 5 000 | - | - |
Välittäjätilasto
Dataa ei löytynyt